Fla. Admin. Code Ann. R. 64B16-26.304 - Subject Matter for Nuclear Pharmacist License Renewal Continuing Education Programs
(1) A
licensee completing the continuing education requirement for nuclear pharmacist
license renewal pursuant to Rule
64B16-26.103, F.A.C., shall
complete twenty-four (24) additional hours per biennium of coursework each two
year period by or through a Committee approved provider, instructionally
designed to provide in-depth treatment of nuclear pharmacy practice with
suggested subject matter set out in subsection (2), of this rule.
(2) Content of nuclear pharmacist continuing
education program.
(a) Application of
radiopharmaceutical theory in a practice or a research setting with respect to
the drug products and their clinical application. Provision of drug and
radiopharmaceutical information as it pertains to optimal handling and use of
these products in a clinical setting.
(b) Effective communication skills in a
multi-disciplinary environment with patients, nuclear medicine physicians,
nuclear medicine technologists, radiation safety personnel and other nuclear
pharmacists. The multi-faceted regulatory environment requires such skills in
the preparation and maintenance of a radioactive by-product materials license,
the identification and reporting of adverse reactions and misadministration,
instances of poor product performance, environmental and personnel radiation
safety.
(c) Application of the most
rigorous and up-to-date principles of radiation safety and quality assurance in
order to assure regulatory compendia, and operational standards for drug and
radiopharmaceutical products and equipment. Recordkeeping and other
documentation activities essential to procurement, storage, compounding,
handling and use, distribution and disposal should be emphasized.
(d) Management of a nuclear pharmacy unit in
accordance with regulatory and administrative agencies' requirements.
(e) Advances in drug, radiopharmaceutical or
related technology (including, but not limited to: monoclonal antibodies,
magnetic resonance imaging, computed tomography, positron-emission tomography,
radioplaque and other contact enhancement agents, radioimmunoassay) with
emphasis on paragraphs (a)-(d), above, for such new
agents.
Notes
Rulemaking Authority 465.005, 465.0126 FS. Law Implemented 465.0126 FS.
New 1-18-05.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.